Cargando…

Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer

BACKGROUND: Accurate identification of pelvic lymph node metastasis (PLNM) in patients with prostate cancer (PCa) is crucial for determining appropriate treatment options. Here, we built a PLNM-Risk calculator to obtain a precisely informed decision about whether to perform extended pelvic lymph nod...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Ying, Bao, Jie, Song, Yang, Bao, Mei-Ling, Jiang, Ke-Wen, Zhang, Jing, Yang, Guang, Hu, Chun-Hong, Shi, Hai-Bin, Wang, Xi-Ming, Zhang, Yu-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167242/
https://www.ncbi.nlm.nih.gov/pubmed/34049247
http://dx.doi.org/10.1016/j.ebiom.2021.103395
_version_ 1783701654382575616
author Hou, Ying
Bao, Jie
Song, Yang
Bao, Mei-Ling
Jiang, Ke-Wen
Zhang, Jing
Yang, Guang
Hu, Chun-Hong
Shi, Hai-Bin
Wang, Xi-Ming
Zhang, Yu-Dong
author_facet Hou, Ying
Bao, Jie
Song, Yang
Bao, Mei-Ling
Jiang, Ke-Wen
Zhang, Jing
Yang, Guang
Hu, Chun-Hong
Shi, Hai-Bin
Wang, Xi-Ming
Zhang, Yu-Dong
author_sort Hou, Ying
collection PubMed
description BACKGROUND: Accurate identification of pelvic lymph node metastasis (PLNM) in patients with prostate cancer (PCa) is crucial for determining appropriate treatment options. Here, we built a PLNM-Risk calculator to obtain a precisely informed decision about whether to perform extended pelvic lymph node dissection (ePLND). METHODS: The PLNM-Risk calculator was developed in 280 patients and verified internally in 71 patients and externally in 50 patients by integrating a set of radiologists’ interpretations, clinicopathological factors and newly refined imaging indicators from MR images with radiomics machine learning and deep transfer learning algorithms. Its clinical applicability was compared with Briganti and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms. FINDINGS: The PLNM-Risk achieved good diagnostic discrimination with areas under the receiver operating characteristic curve (AUCs) of 0.93 (95% CI, 0.90-0.96), 0.92 (95% CI, 0.84-0.97) and 0.76 (95% CI, 0.62-0.87) in the training/validation, internal test and external test cohorts, respectively. If the number of ePLNDs missed was controlled at < 2%, PLNM-Risk provided both a higher number of ePLNDs spared (PLNM-Risk 59.6% vs MSKCC 44.9% vs Briganti 38.9%) and a lower number of false positives (PLNM-Risk 59.3% vs MSKCC 70.1% and Briganti 72.7%). In follow-up, patients stratified by the PLNM-Risk calculator showed significantly different biochemical recurrence rates after surgery. INTERPRETATION: The PLNM-Risk calculator offers a noninvasive clinical biomarker to predict PLNM for patients with PCa. It shows improved accuracy of diagnosis support and reduced overtreatment burdens for patients with findings suggestive of PCa. FUNDING: This work was supported by the Key Research and Development Program of Jiangsu Province (BE2017756) and the Suzhou Science and Technology Bureau-Science and Technology Demonstration Project (SS201808).
format Online
Article
Text
id pubmed-8167242
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81672422021-06-05 Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer Hou, Ying Bao, Jie Song, Yang Bao, Mei-Ling Jiang, Ke-Wen Zhang, Jing Yang, Guang Hu, Chun-Hong Shi, Hai-Bin Wang, Xi-Ming Zhang, Yu-Dong EBioMedicine Research Paper BACKGROUND: Accurate identification of pelvic lymph node metastasis (PLNM) in patients with prostate cancer (PCa) is crucial for determining appropriate treatment options. Here, we built a PLNM-Risk calculator to obtain a precisely informed decision about whether to perform extended pelvic lymph node dissection (ePLND). METHODS: The PLNM-Risk calculator was developed in 280 patients and verified internally in 71 patients and externally in 50 patients by integrating a set of radiologists’ interpretations, clinicopathological factors and newly refined imaging indicators from MR images with radiomics machine learning and deep transfer learning algorithms. Its clinical applicability was compared with Briganti and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms. FINDINGS: The PLNM-Risk achieved good diagnostic discrimination with areas under the receiver operating characteristic curve (AUCs) of 0.93 (95% CI, 0.90-0.96), 0.92 (95% CI, 0.84-0.97) and 0.76 (95% CI, 0.62-0.87) in the training/validation, internal test and external test cohorts, respectively. If the number of ePLNDs missed was controlled at < 2%, PLNM-Risk provided both a higher number of ePLNDs spared (PLNM-Risk 59.6% vs MSKCC 44.9% vs Briganti 38.9%) and a lower number of false positives (PLNM-Risk 59.3% vs MSKCC 70.1% and Briganti 72.7%). In follow-up, patients stratified by the PLNM-Risk calculator showed significantly different biochemical recurrence rates after surgery. INTERPRETATION: The PLNM-Risk calculator offers a noninvasive clinical biomarker to predict PLNM for patients with PCa. It shows improved accuracy of diagnosis support and reduced overtreatment burdens for patients with findings suggestive of PCa. FUNDING: This work was supported by the Key Research and Development Program of Jiangsu Province (BE2017756) and the Suzhou Science and Technology Bureau-Science and Technology Demonstration Project (SS201808). Elsevier 2021-05-25 /pmc/articles/PMC8167242/ /pubmed/34049247 http://dx.doi.org/10.1016/j.ebiom.2021.103395 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Hou, Ying
Bao, Jie
Song, Yang
Bao, Mei-Ling
Jiang, Ke-Wen
Zhang, Jing
Yang, Guang
Hu, Chun-Hong
Shi, Hai-Bin
Wang, Xi-Ming
Zhang, Yu-Dong
Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
title Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
title_full Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
title_fullStr Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
title_full_unstemmed Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
title_short Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
title_sort integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167242/
https://www.ncbi.nlm.nih.gov/pubmed/34049247
http://dx.doi.org/10.1016/j.ebiom.2021.103395
work_keys_str_mv AT houying integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT baojie integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT songyang integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT baomeiling integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT jiangkewen integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT zhangjing integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT yangguang integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT huchunhong integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT shihaibin integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT wangximing integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer
AT zhangyudong integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer